Sodium Restriction in the Management of Cirrhotic Ascites
Comparison of Efficacy of 2 Gram Versus 4 Gram Sodium Restriction in the Management of Cirrhotic Ascites
Sponsor: University of Texas Southwestern Medical Center
Terminated
Failure to recruit.
Other terminated trials from University of Texas Southwestern Medical Center
- Cervical Dysplasia · Phase NA · Jun 2025
- Bronchiolitis · Phase NA · Apr 2025
- Healthy · Mar 2025
- Burn Injury · Mar 2025
- Urinary Tract Infections · Phase PHASE4 · Dec 2024
See all terminations from University of Texas Southwestern Medical Center
Listed as NCT00548366, this PHASE4 trial focuses on Ascites and remains terminated or withdrawn. Sponsored by University of Texas Southwestern Medical Center, it has been updated 5 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE4
First recorded
Oct 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Texas Southwestern Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .